Real-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance-associated substitution test

In Hee Kim

Real-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance-associated substitution test

In Hee Kim

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Journal of Medical Virology
State	Published - 2019.12.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{5cb8a8d9e8b8444d94f79a38d4c7690d,

title = "Real-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance-associated substitution test",

author = "Kim, \{In Hee\}",

year = "2019",

month = dec,

day = "1",

language = "Korean",

journal = "Journal of Medical Virology",

issn = "0146-6615",

}

TY - JOUR

T1 - Real-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance-associated substitution test

AU - Kim, In Hee

PY - 2019/12/1

Y1 - 2019/12/1

M3 - Journal article

SN - 0146-6615

JO - Journal of Medical Virology

JF - Journal of Medical Virology

ER -